Critical care issues in lung and heart transplantation

Critical Care Clinics

Volumn 19, Issue 2, 2003, Pages 209-231

  Goudarzi, Behnam M ^a   Bonvino, Steven ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHOXSALEN; NITRIC OXIDE; PROSTACYCLIN; TACROLIMUS;

BRONCHITIS; EXTRACORPOREAL OXYGENATION; FIBEROPTIC BRONCHOSCOPY; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTENSIVE CARE; LUNG TRANSPLANTATION; NUTRITIONAL STATUS; ORGAN DONOR; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PUVA; RECIPIENT; REPERFUSION INJURY; REVIEW; SURGICAL TECHNIQUE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION; VASCULAR DISEASE;

CRITICAL CARE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; MIDDLE AGED; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROGNOSIS;

EID: 0037378493     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(02)00054-4     Document Type: Review

References (146)

1. De Hoyos AL, Patterson GA, Maurer JR, et al. Pulmonary transplantation: early and late results. J Thorac Cardiovasc Surg 1992;103:295-306.
2. Hardy JD, Webb JR, Dalton ML, et al. Lung homotransplantation in man. JAMA 1963;186:1865-74.
3. Veith FJ, Kamholz SL, Mollenkopf FP, et al. Lung transplantation. Transplantation 1983;35:271-8.
4. Veith FJ, Koemer SK, et al. Problems in the management of human LTx patients. Vasc Surg 1974;8:273-82.
5. Veith FJ, Koerner SK, Siegelman SS, et al. Single LTx in experimental and human emphysema. Ann Surg 1973;178:463-76.
6. Dubois P, Choiniere L, Cooper JD. Bronchial omentopexy in canine lung allotransplantation. Ann Thorac Surg 1984;38:211.
7. Toronto Lung Transplant Group. Unilateral LTx for pulmonary fibrosis. N Engl J Med 1986;314:1140-5.
8. th official report 2001. J Heart Lung Transplant 2001;20:805.
9. Cooper DKC. Christiaan Neethling Bamard. Clin Cardiol 2001;24:527-8.
10. Hosenpud JD, Bennett LE, Keck BM, et al. The registry of the International Society for Heart and Lung Transplantation: 17th official report - 2000. J Heart Lung Transplant 2000;19:909-31.
11. Barr ML. Current status of heart and lung tx. Transplant Proc 2001;33:3564-5.
12. Sood N, Paradowski LJ, Yankaskas JR. Outcomes of intensive care in adults with cystic fibrosis. Am J Respir Crit Care Med 2001;163:335-8.
13. Baylor University Medical Center Cardiothoracic Transplantation. Criteria for heart and lung transplant. Available at: http://www.baylordallas.edu/BaylorsBest/Services2.asp/PagelD+1338-4/23/02.
14. Miniati DN, Robbins RC. Heart transplantation: a thirty-year perspective. Annu Rev Med 2002; 53:189-205.
15. The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS) /International Society for Heart and Lung Transplantation (ISHLT). International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998;158(1):335-9.
16. Grover FL, Fullerton DA, Zamora MR, et al. The past, present and future of LTx. Am J Surg 1997;173:523-33.
17. Kaza AK, Dietz JF, Kem JA, et al. Coronary risk stratification in patients with end-stage lung disease. J Heart Lung Transplant 2002;21(3):334-9.
18. Monforte V, Roman A, Aviles B, et al. Coronary angiography in patients undergoing evaluation for LTx. Transplant Proc 2002;34:187.
19. Hadjiliadis D, Spom TA, Perfect JR, et al. Outcome of LTx in patients with mycetomas. Chest 2000;121(1):128-34.
20. Hadjiliadis D, Tapson VF, Davis RD, et al. Prognostic value ofcarcinoembryonic antigen levels in patients who undergo LTx. J Heart Lung Transplant 2001;20(12):1305-9.
21. UNOS Critical Data. U.S. facts about transplantation. Available at: http://www.unos.org/News-room/critdata_main.htm-4/23/02.
22. Scottish Intercollegiate Guidelines Network. Section 10: cardiac transplantation. Available at: http://www.sign.ac.uk.
23. Copeland JG, McCarthy M. University of Arizona, Cardiac transplantation: changing patterns in selection and outcomes. Clin Transpl 2001:203-7.
24. Blanche C, Blanche DA, Kearney B, et al. Heart transplantation in patients seventy years ofage and older: a comparative analysis ofoutcome. J Thorac Cardiovasc Surg 2001;121(3):532-41.
25. Jenkinson S, Levine SM. Lung transplantation. Dis Mon 1994;40(1):1-38.
26. 2000 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: transplant data 1989-1998. (2001, Feb 16) Rockville, MD: UNOS and Richmond, VA: HHS-HRSA-OSP-DOT.
27. Bhorade SM, Vigneswaran W, McCabe MA, et al. Liberization of donor criteria may expand the donor pool without adverse consequence in LTx. J Heart Lung Transplant 2000;19(12):1199-204.
28. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for LTx. Am J Respir Crit Care Med 1999;160(1):265-71.
29. Pierre AF, Sekine Y, Hutcheon MA, et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002;123:421-8.
30. Stames VA, Lewiston NJ, Luikart H, et al. Current trends in LTx: lobar Tx and expanded use of single lungs. J Thorac Cardiovasc Surg 1992;104:1060-5.
31. Goldsmith MF. Mother to child: first living donor LTx. JAMA 1990;264:2724.
32. Barr ML, Schenkel FA, Cohen RG, et al. Recipient and donor outcomes in living related and unrelated lobar Tx. Transplant Proc 1998;30:2261-3.
33. Ciccone AM, Stewart KC, Meyers BF, et al. Does donor cause of death affect the outcome of LTx? J Thorac Cardiovasc Surg 2002;123(3):429-34; discussion 434-6.
34. Baldwin JC, Anderson JL, Boucek MM, et al. Twenty-fourth Bethesda conference: cardiac transplantation. Task force 2: donor guidelines. J Am Coll Cardiol 1993;22:15-20.
35. Blanche C, Kamlot A, Blanche DA, et al. Heart transplantation with donors fifty years of age and older. J Thorac Cardiovasc Surg 2002;123(4):810-5.
36. Kaiser LR, Pasque MK, Trulock EP, et al. Bilateral sequential LTx: the procedure of choice for double-lung replacement. Ann Thorac Surg 1991;52:438-46.
37. Plochl W, Pezawas L, Artemiou O, et al. Nutritional status, ICU duration and ICU mortality in lung transplant patients. Intensive Care Med 1996;22(11):1179-85.
38. Greer ME, Webb JP. For those who wait... Care of the status 1 patient awaiting cardiac transplantation. Crit Care Nurs Clin N Am 2000;12:(1):49-60.
39. Aarson KD, Eppinger MJ, Dyke DB, et al. Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002;39(8):1247-54.
40. El-Banayosy A, Korfer R, Arusoglu L, et al. Device and patient management in a bridge-to-transplant setting. Ann Thorac Surg 2001;71:S98-102.
41. Cochran RP, Starkey TD, Panos AL, et al. Ambulatory intraaortic balloon pump use as bridge to heart transplant. Ann Thorac Surg 2002;74(3):746-51.
42. Khan S, Salloum J, O'Donovan PB, et al. Acute pulmonary edema after lung transplantation. Chest 1999;116:187-94.
43. Bund M, Struber M, Heine J, et al. Effect of lung allograft ischemia duration on postreperfusion graft function and postoperative course. J Thorac Cardiovasc Surg 1998;46(2):93-6.
44. Karamsetty MR, Klinger JR. NO: more than just a vasodilator in LTx. Am J Respir Cell Mol Biol 2002;26:1-5.
45. Chan CY, Chen YS, Ko WJ, et al. Extracorporeal membrane oxygenation support for single LTx in a patient with primary pulmonary hypertension. J Heart Lung Transplant 1998;17(3):325-7.
46. Ko WJ, Chen YS, Lee YC. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in LTx operations. Artif Organs 2001;25(8):607-12.
47. Sheridan BC, Hodges TN, Zamora MR, et al. Acute and chronic effects of bilateral LTx without cardiopulmonary bypass on the first transplant lung. Ann Thorac Surg 1998;66:1755-8.
48. Ko WJ, Chen YS, Chou NK, et al. ECMO support for single LTx. Transplant Proc 2001;33:1939-41.
49. Kadner A, Chen RH, Adams DH. Heterotopic heart transplantation: experimental development and clinical experience. Eur J Cardiothorac Surg 2000;17(4):474-81.
50. Todd TRJ. Early postoperative management following LTx. Clin Chest Med 1990;11(2):259-67.
51. George EL, Hoffman LA, Boujoukos A, et al. Effects of positioning on oxygenation in single LTx recipients. Am J Crit Care 2002;11(1):66-75.
52. Diette GB, Wiener CM, White Jr P. The higher risk of bleeding in LTx recipients from bronchoscopy is independent of traditional bleeding risks, results of a prospective cohort study. Chest 1999;115:397-402.
53. Reynaud-Gaubert M, Thomas P, Gregoire R, et al. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of LTx recipients. Eur J Cardiothorac Surg 2002;21(1):60-6.
54. Doering TJ, Fieguth HG, Steuemagel B, et al. External stimuli in the form of vibratory massage after heart or lung transplantation. Am J Phys Med Rehabil 1999;789(2):108-10.
55. Carrier M, Blaise G, Belisle S, et al. Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 1999;18(7):664-7.
56. Esmore DS, Spratt PM, Branch JM, et al. Right ventricular assist and prostacyclin infusion for allograft failure in the presence of high pulmonary vascular resistance. J Heart Transplant 1990;9:136-41.
57. Barzaghi N, Olivei M, Minzioni G, et al. ECMO and inhaled nitric oxide for cardiopulmonary failure after heart retransplantation. Ann Thorac Surg 1997;63:533-5.
58. Vaska PL. Common infections in heart transplant patients. Am J Crit Care 1993;2(2):145-54.
59. Palmer SM, Alexander BD, Sanders LL, et al. Significance ofblood stream infection after LTx: analysis in 176 consecutive patients. Transplantation 2000;69(11):2360-6.
60. Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobulinemia in LTx recipients. Transplantation 2001;71(2):242-6.
61. Husni RN, Gordon SM, Longworth DL, et al. CMV infection is a risk factor for invasive aspergillosis in LTx recipients. Clin Infect Dis 1998;26(3):753-5.
62. Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after LTx. Chest 1997;112:1160-4.
63. Utili R, Zampino R, De Vivo F, et al. Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment. Clin Transplant 2000;14:282-6.
64. Medscape Transplantation. CMV infection and disease in solid organ transplant recipients. Available at: http://www.medscape.com/viewarticle/424607_3-4/23/02.
65. Zamora MR. Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in LTx. Transpl Infect Dis 2001;3(Supp 2):49-56.
66. Speich R, Thurnheer R, Gaspert A, et al. Efficacy and cost effectiveness of oral ganciclovir in the prevention of CMV disease after LTx. Transplantation 1999;67(2):315-20.
67. Brumble LM, Milstone AP, Loyd JE, et al. Prevention of cytomegalovirus infection and disease after LTx: results using unique regimen employing delayed ganciclovir. Chest 2002;121(2):407-14.
68. Kesten S, Chaparro C. Mycobacterial infections in LTx patients. Chest 1999;115:741-5.
69. Schulman LL, Scully B, McGregor CC, et al. Pulmonary tuberculosis after LTx. Chest 1997;111:1459-62.
70. Christie JD, Bavaria JE, Palevsky HI, et al. Primary graft failure following LTx. Chest 1998;114:51-60.
71. Kundu S, Herman SJ, Winton TL. Reperfusion edema after LTx: radiologic manifestation. Radiology 1998;206(1):75-80.
72. Anderson DC, Glazer HS, Semenkovich JW, et al. Lung transplant edema: chest radiography after LTx - the first 10 days. Radiology 1995;195:275-81.
73. King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000;69:1681-5.
74. Bando K, Keenan RJ, Paradis IL, et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg 1994;58:1336-42.
75. Boujoukos AJ, Martich GD, Vega JD, et al. Reperfusion injury in single lung transplant recipients with pulmonary hypertension and emphysema. J Heart Lung Transplant 1997;16:439-48.
76. Davis Jr RD, Trulock EP, Manley J, et al. Differences in early results after single lung transplantation. Ann Thorac Surg 1994;58:1327-35.
77. Huerd SS, Hodges TN, Grover FL, et al. secondary pulmonary hypertension does not adversely affect outcome after single LTx. J Thorac Cardiovasc Surg 2000;119(3):458-65.
78. Corris PA, Odom NJ, Jackson G, et al. Reimplantation injury after LTx in a rat model. J Heart Lung Transplant 1987;6:234-7.
79. Klausner JM, Paterson IS, Kobzik L, et al. Oxygen free radicals mediate ischemia-induced lung injury. Surgery 1989;105:192-9.
80. Prop J, Ehrie MG, Crapo JD, et al. Reimplantation response in isolated rat lungs. J Thorac Cardiovasc Surg 1984;87:702-11.
81. Seibert AF, Haynes J, Taylor A. Ischemia-reperfusion in the isolated rat lung: role of flow and endogenous leukocytes. Am Rev Respir Dis 1993;147:270-5.
82. Serrick C, La Franchesca S, Giaid A, et al. Cytokine interleukin-2, Tumor necrosis factor alpha and interferon gamma release after ischemia/reperfusion injury in a novel lung autograft animal model. Am J Respir Crit Care Med 1995;152:277-82.
83. Su M, Chi EY, Bishop MJ, et al. Lung mast cells increase in number and degranulate during pulmonary artery occlusion/reperfusion injury in dogs. Am Rev Respir Dis 1993;147:448-56.
84. Novick RJ, Gehman KE, Ali IS, et al. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996;62:302-4.
85. Pinsky DJ. The vascular biology of heart and lung preservation for transplantation. Thromb Haemost 1995;74:58-65.
86. Ware LB, Golden JA, Finkbeiner WE, et al. Alveolar epithelial fluid transport capacity in reperfusion lung injury after LTx. Am J Respir Crit Care Med 1999;159:980-8.
87. Kaplan JD, Trulock EP, Cooper JD, et al. Pulmonary vascular permeability after LTx. Am Rev Respir Dis 1991;145:954-7.
88. De Perrot M, Sekine Y, Fischer S, et al. Interlukin-8 release during early reperfusion predicts graft function in human LTx. Am J Respir Crit Care Med 2002;165(2):211-5.
89. Rocco M, Conti G, Antonelli M, et al. Non-invasive pressure support ventilation in patients with acute respiratory failure after bilateral LTx. Intensive Care Med 2001;27(10):1622-6.
90. Gavazzeni V, lapichino G, Mascheroni D, et al. Prolonged independent respiratory treatment after single LTx in pulmonary emphysema. Chest 1993;103:96-100.
91. Popple C, Higgins TL, McCarthy P, et al. Unilateral auto-PEEP in the recipient ofa single LTx. Chest 1996;103:297-9.
92. Adatia I, Lillehei C, Arnold JH, et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after LTx. Ann Thorac Surg 1994;57:1311-8.
93. Date H, Triantafillou AN, Trulock EP, et al. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996;111:913-9.
94. Struber M, Brandt M, Cremer J, et al. Therapy for lung failure using nitric oxide inhalation and surfactant replacement. Ann Thorac Surg 1996;61:1543-5.
95. Novick RJ. Innovative techniques to enhance lung preservation. J Thorac Cardiovasc Surg 2002;123:3-5.
96. Meyers BF, Sundt III TM, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after LTx. J Thorac Cardiovasc Surg 2000;120(1):20-6.
97. Jurmann MJ, Schaefers HJ, Demertzis S, et al. Emergency LTx after ECMO. ASAIO J 1993;39(3):M448-52.
98. Jurmann MJ, Haverich A, Demertzis S, et al. Extracorporeal membrane oxygenation as a bridge to LTx. Eur J Cardiothorac Surg 1991;5(2):94-7.
99. Novick RJ, Kaye MP, Patterson GA, et al. Redo LTx: a North American-European experience. J Heart Lung Transplant 1993;12:5-16.
100. Wekerle T, Klepetko W, Wisser W, et al. Lung retransplantation: institutional report on a series of 20 patients. J Heart Lung Transplant 1996;15:182-9.
101. Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of the airways after pulmonary Tx. Ann Surg 1988;208:371-8.
102. Gotway MB, Dawn SK, Sellami D, et al. Acute rejection following LTx: limitations in accuracy of thin-section CT for diagnosis. Radiology 2001;221(1):207-12.
103. Higenbottam T, Stewart S, Penketh A, et al. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation 1988;46:532-9.
104. Berry GJ, Brunt EM, Chamberlain D, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group. J Heart Transplant 1990;9:593-601.
105. Garg K, Zamora MR, Tuder R, et al. LTx: indications, donor and recipient selection, and imaging of complications. Radiographics 1996;16(2):355-67.
106. Sarahrudi K, Carretta A, Wisser W, et al. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after LTx. Transpl Int 2002;15(1):24-8.
107. Vitulo P, Oggionni T, Cascina A, et al. Efficacy of tacrolimus rescue therapy in refractory acute rejection after LTx. J Heart Lung Transplant 2002;21(4):435-9.
108. Pierson RN. Late graft failure. Lessons from clinical and experimental thoracic organ Tx. Graft 2000;3:88.
109. Gast KK, Viallon M, Eberle B, et al. MRI in LTx recipients using hyperpolarized 3He: comparison with CT. J Magn Reson Imaging 2002;15(3):268-74.
110. Massicot-Fisher J, Noel P, Madsen JC. Recommendations of the National Heart, Lung and Blood Institute Heart and Lung Tolerance Working Group. Transplantation 2001;72(8):1467-70.
111. Kubo SH, Naftel DC, Mills RMJ, et al. Cardiac Transplant Research Database Group. Risk factors for late recurrent rejection after heart transplantation: a multi-institutional, multivariable analysis. J Heart Lung Transplant 1995;14:409-18.
112. Dall'Amico R, Montini G, Murer L, et al. Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection. Int J Artif Organs 2000;23(1):49-54.
113. Kobashigawa J. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Curr Control Trials Cardiovasc Med 2000;1(3):166-71.
114. Raybum BK. Posttransplantation complications: early graft failure, acute rejection and cardiac allograft vasculopathy. Available at: http://www.medscape.com?viewarticle/418482-4/23/02.
115. Yamani MH, Haji SA, Starling RC, et al. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. J Am Coll Cardiol 2002;39(6):970-7.
116. Musci M, Loebe M, Wellnhofer E, et al. Coronary angioplasty, bypass surgery, and retransplantation in cardiac transplant patients with graft coronary disease. Thorac Cardiovasc Surg 1998;46(5):268-74.
117. Schnetzler B, Drobinski G, Dorent R, et al. The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 2000;19(6):557-65.
118. Takano Y, Currier J, Yeatman L, et al. Cutting balloon angioplasty for cardiac transplant vasculopathy. J Heart Lung Transplant 2002;21(8):910.
119. Topaz O, Janin Y, Bernardo N, et al. Coronary revascularization in heart transplant recipients by excimer laser angioplasty. Lasers Surg Med 2000;26(5):425-31.
120. Sarsam MA, Yonan NA, Beton D, et al. Early pulmonary vein thrombosis after single LTx. J Heart Lung Transplant 1993;12:17-9.
121. Leibowitz DW, Smith CR, Michler RE, et al. Incidence of pulmonary vein complications after LTx: a prospective TEE study. J Am Coll Cardiol 1994;24:671-5.
122. Schmid C, Gulba DC, Heublein B, et al. Systemic recombinant tissue plasminogen activator lysis for left atrial thrombus formation after single LTx. Ann Thorac Surg 1992;53:338-40.
123. Schulman LL, Anandarangam T, Leibowitz DW, et al. Four-year prospective study of pulmonary venous thrombosis after LTx. J Am Soc Echocardiogr 2001;14(8):806-12.
124. Riberi A, Ambrosi P, Habib G, et al. Systemic embolism: a serious complication after cardiac transplantation avoidable by bicaval technique. Eur J Cardiothorac Surg 2001;19(3):307-11.
125. Mulligan MS. Endoscopic management of airway complications after LTx. Chest Surg Clin N Am 2001;11(4):907-15.
126. Shumway SJ, Hertz MI, Maynard R, et al. Airway complications after lung and heart-lung Tx. Transplant Proc 1993;25(1):1165-6.
127. Lima O, Goldberg M, Peters WJ, et al. Bronchial omentopexy in canine LTx. J Thorac Cardiovasc Surg 1982;83:418-21.
128. Herridge MS, de Hoyos AL, Chaparro C. Pleural complications in LTx recipients. J Thorac Cardiovasc Surg 1995;110(1):22-6.
129. Kirklin JK, Holm A, Aldrete JS, et al. Gastrointestinal complications after cardiac Tx: potential benefits of early diagnosis and prompt surgical intervention. Ann Surg 1990;211:538-41.
130. Smith P, Slaughter MS, Petty MG, et al. Abdominal complications following LTx. J Heart Lung Transplant 1995;14:44-51.
131. Steck TB, Costanzo-Nordin MR, Keshavarzian A. Prevalence and management of cholelithiasis in heart Tx patients. J Heart Lung Transplant 1991;10(6):1029-32.
132. Gupta D, Sakorafas GH, McGregor CG, et al. Management of biliary tract disease in heart and lung transplant patients. Surgery 2000;128(4):641-9.
133. Gulbis B, Adler M, Ooms HA, et al. Liver-function studies in heart Tx recipients treated with cyclosporine A. Clin Chem 1988;34(9):1772-4.
134. Stukas Jr AA, Dew MA, Switzer GE, et al. PTSD in heart transplant recipients and their primary family caregivers. Psychosomatics 1999;40(3):212-21.
135. Knisely BL, Mastey LA, Collins J, et al. Imaging of cardiac transplantation complications. Radiographics 1999;19(2):321-39.
136. Mercadal L, Petitclerc T, Assogba U, et al. Hemolytic and uremic syndrome after heart transplantation. Am J Nephrol 2000;20(5):418-20.
137. Yankah AC, Musci M, Weng Y, et al. Tricuspid valve dysfunction and surgery after orthotopic cardiac transplantation. Eur J Cardiothorac Surg 2000;17(4):343-8.
138. Grady KL. Posttransplant complications: renal insufficiency and osteoporosis. Available at: http://www.medscape.com/viewarticle/418481-4/23/02.
139. Oaks TE, Wannenberg T, Close SA, et al. Steroid-free maintenance immunosuppression after heart transplantation. Ann Thorac Surg 2001;72(1):102-6.
140. Meyers BF, Lynch J, Trulock EP, et al. LTx: a decade of experience. Ann Surg 1999;230(3):362-70.
141. Schulman LL, Weinberg AD, McGregor CC, et al. Influence of lung injury on early post-operative survival after LTx. Ann Transplant 2000;5(3):20-5.
142. Brann WM, Bennett LE, Keck BM, et al. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. J Heart Lung Transplant 1998;17(4):374-82.
143. Everett JE, Djalilian AR, Kubo SH, et al. Heart transplantation for patients over age 60. Clin Transplant 1996;10:478-81.
144. Martinelli L, Rinaldi M, Pederzolli C, et al. Different results of cardiac transplantation in patients with ischemic and dilated cardiomyopathy. Eur J Cardiothorac Surg 1995;9(11):644-50.
145. Lee KH, Martich GD, Boujoukos AJ, et al. Predicting ICU length of stay following single lung transplantation. Chest 1996;110:1014-7.
146. Cooper DK, Keogh AM, Brink J, et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 2000;19(12):1125-65.